Q3 2021 Holdings
Filed 2021-11-12 | 40 holdings | $173.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Affirm Hldgs Inc(AFRM) | COM CL A | 00827B106 | $89.8M | 753,804 | 51.7% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $82.3M | 4,105,095 | 47.4% |
| Apple Inc(AAPL) | COM | 037833100 | $266.5K | 1,883,445 | 0.2% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $258.1K | 7,142,856 | 0.1% |
| Facebook Inc(META) | CL A | 30303M102 | $242.0K | 713,073 | 0.1% |
| Scientific Games Corp(LNWO) | COM | 80874P109 | $222.5K | 2,678,571 | 0.1% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $163.3K | 61,070 | 0.1% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $36.3K | 101,448 | 0.0% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $34.7K | 1,509,254 | 0.0% |
| Ishares TR(IVV) | CORE S&P500 ETF | 464287200 | $28.2K | 65,342 | 0.0% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $27.1K | 186,143 | 0.0% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $26.2K | 1,163,601 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $18.4K | 670,382 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $17.1K | 541,124 | 0.0% |
| Rocket LAB USA Inc | COM | 773122106 | $16.1K | 1,000,000 | 0.0% |
| Spdr Gold TR(GLD) | GOLD SHS | 78463V107 | $15.1K | 91,955 | 0.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $14.4K | 778,517 | 0.0% |
| Purecycle Technologies Inc(PCT) | COM | 74623V103 | $14.2K | 1,069,600 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $13.9K | 673,270 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $12.8K | 510,354 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $11.6K | 410,714 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $11.5K | 498,001 | 0.0% |
| Meli Kaszek Pioneer Corp | CLASS A ORD | G5S74L106 | $11.1K | 1,000,000 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $9.5K | 562,379 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.4K | 314,762 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $9.2K | 708,385 | 0.0% |
| Vanguard Tax-Managed Intl FD(VEA) | FTSE DEV MKT ETF | 921943858 | $8.2K | 162,699 | 0.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $5.9K | 229,144 | 0.0% |
| Surrozen Inc | COM | 86889P109 | $5.9K | 826,852 | 0.0% |
| Ishares TR(IJR) | CORE S&P SCP ETF | 464287804 | $5.4K | 49,559 | 0.0% |
| FS Development Corp II | COM CL A | 30318F100 | $4.0K | 400,000 | 0.0% |
| Vanguard Intl Equity Index F(VWO) | FTSE EMR MKT ETF | 922042858 | $3.7K | 73,804 | 0.0% |
| Ishares TR(IJH) | CORE S&P MCP ETF | 464287507 | $3.3K | 12,683 | 0.0% |
| Decibel Therapeutics Inc | COM | 24343R106 | $2.5K | 328,798 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $2.4K | 332,610 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.7K | 107,252 | 0.0% |
| Gemini Therapeutics Inc | COM | 36870G105 | $1.0K | 250,000 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $918 | 131,847 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $124 | 108,333 | 0.0% |
| Amplitude CL A ORD (NMQ)(AMPL) | CLASS A ORD | 03213A104 | $29 | 540 | 0.0% |